FI851611A0 - Heterocykliska aminokomponenter. - Google Patents

Heterocykliska aminokomponenter.

Info

Publication number
FI851611A0
FI851611A0 FI851611A FI851611A FI851611A0 FI 851611 A0 FI851611 A0 FI 851611A0 FI 851611 A FI851611 A FI 851611A FI 851611 A FI851611 A FI 851611A FI 851611 A0 FI851611 A0 FI 851611A0
Authority
FI
Finland
Prior art keywords
sup
alkyl
compounds
heterocyclic amino
amino component
Prior art date
Application number
FI851611A
Other languages
English (en)
Other versions
FI84069C (fi
FI84069B (fi
FI851611L (fi
Inventor
John Kitchin
Peter Clive Cherry
Adrian John Pipe
Andrew James Crame
Alan David Borthwick
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848410456A external-priority patent/GB8410456D0/en
Priority claimed from GB858503975A external-priority patent/GB8503975D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI851611A0 publication Critical patent/FI851611A0/fi
Publication of FI851611L publication Critical patent/FI851611L/fi
Application granted granted Critical
Publication of FI84069B publication Critical patent/FI84069B/fi
Publication of FI84069C publication Critical patent/FI84069C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
FI851611A 1984-04-24 1985-04-24 Foerfarande foer framstaellning av en terapeutiskt aktiv heterocyklisk aminofoerening. FI84069C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8410456 1984-04-24
GB848410456A GB8410456D0 (en) 1984-04-24 1984-04-24 Chemical compounds
GB8503975 1985-02-15
GB858503975A GB8503975D0 (en) 1985-02-15 1985-02-15 Chemical compounds

Publications (4)

Publication Number Publication Date
FI851611A0 true FI851611A0 (fi) 1985-04-24
FI851611L FI851611L (fi) 1985-10-25
FI84069B FI84069B (fi) 1991-06-28
FI84069C FI84069C (fi) 1991-10-10

Family

ID=26287645

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851611A FI84069C (fi) 1984-04-24 1985-04-24 Foerfarande foer framstaellning av en terapeutiskt aktiv heterocyklisk aminofoerening.

Country Status (21)

Country Link
US (1) US4880801A (fi)
EP (2) EP0359290B1 (fi)
JP (2) JPH02270878A (fi)
KR (1) KR920003065B1 (fi)
AT (1) ATE55605T1 (fi)
AU (1) AU577367B2 (fi)
CA (1) CA1256111A (fi)
CS (1) CS402491A3 (fi)
CY (2) CY1532A (fi)
DE (2) DE3587511T2 (fi)
DK (2) DK160556C (fi)
ES (2) ES8607311A1 (fi)
FI (1) FI84069C (fi)
GB (3) GB2157691B (fi)
GR (1) GR850993B (fi)
HK (2) HK42890A (fi)
IL (1) IL75011A (fi)
MX (1) MX9203233A (fi)
NZ (1) NZ211885A (fi)
PT (1) PT80344B (fi)
SG (2) SG23590G (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8526210D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical compounds
GB8526209D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical process
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8828032D0 (en) * 1988-12-01 1989-01-05 Glaxo Group Ltd Medicaments
GB9012469D0 (en) * 1990-06-05 1990-07-25 Glaxo Group Ltd Medicaments
GB9119466D0 (en) * 1991-09-12 1991-10-23 Glaxo Group Ltd Chemical compounds
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
CA2522666A1 (en) * 2003-04-18 2004-10-28 Pharmacia & Upjohn Company Llc Combination therapies for chronic obstructive pulmonary disease (copd)
GB2503187A (en) * 2011-09-15 2013-12-25 Univ Sussex Composition for use in the treatment of neurodevelopmental disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485539A1 (fr) * 1980-06-26 1981-12-31 Sori Soc Rech Ind Nouveau derive de pyranno-indole, son procede de preparation et son application en therapeutique
IL70034A0 (en) * 1982-10-25 1984-01-31 Glaxo Group Ltd Heterocyclic amino compounds,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CS402491A3 (en) 1992-10-14
ES542516A0 (es) 1986-06-16
CY1532A (en) 1990-11-16
EP0359290B1 (en) 1993-08-04
JPH02270819A (ja) 1990-11-05
KR920003065B1 (ko) 1992-04-13
DE3587511D1 (de) 1993-09-09
DE3587511T2 (de) 1993-11-18
DK184085A (da) 1985-10-25
GB2201414A (en) 1988-09-01
ES8607311A1 (es) 1986-06-16
HK112093A (en) 1993-10-29
GR850993B (fi) 1985-11-25
AU4166785A (en) 1985-10-31
GB2157691A (en) 1985-10-30
AU577367B2 (en) 1988-09-22
ES8801545A1 (es) 1988-02-01
DK184085D0 (da) 1985-04-24
DK160556B (da) 1991-03-25
FI84069C (fi) 1991-10-10
DK160556C (da) 1991-09-02
MX9203233A (es) 1992-07-01
DK141590A (da) 1990-06-08
SG23590G (en) 1990-07-13
JPH02270878A (ja) 1990-11-05
HK42890A (en) 1990-06-08
GB8802949D0 (en) 1988-03-09
PT80344B (pt) 1987-09-30
GB2201414B (en) 1988-12-29
DK160824C (da) 1991-10-07
PT80344A (en) 1985-05-01
DK141590D0 (da) 1990-06-08
GB8728949D0 (en) 1988-01-27
EP0162593B1 (en) 1990-08-16
ES551509A0 (es) 1988-02-01
GB8510449D0 (en) 1985-05-30
ATE55605T1 (de) 1990-09-15
GB2157691B (en) 1989-07-05
IL75011A (en) 1990-02-09
DK160824B (da) 1991-04-22
SG12293G (en) 1993-04-16
DE3579189D1 (de) 1990-09-20
FI84069B (fi) 1991-06-28
NZ211885A (en) 1988-09-29
FI851611L (fi) 1985-10-25
CY1695A (en) 1994-01-14
CA1256111A (en) 1989-06-20
EP0162593A1 (en) 1985-11-27
US4880801A (en) 1989-11-14
EP0359290A1 (en) 1990-03-21
KR850007259A (ko) 1985-12-02

Similar Documents

Publication Publication Date Title
FI851611A0 (fi) Heterocykliska aminokomponenter.
ES8403437A1 (es) Un procedimiento para obtener derivados de indanilbenzamida.
EP0251574A3 (en) Antifungal derivatives of n-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
DK163783D0 (da) Fremgangsmade til fremstilling af imidazolinderivater
ES527739A0 (es) Un procedimiento para preparar derivados de pirimidina
ES8802489A1 (es) Procedimiento para la obtencion de benzamidas
EP0119540A3 (en) Substituted alkylamine derivatives of 6,11-dihydro-11-oxodibenz (b,e)-oxepins, a process for the preparation and intermediates thereof and their use as medicaments
JPS5344575A (en) Preparation of hydantoin derivatives

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: GLAXO GROUP LIMITED